WebOct 14, 2013 · Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. Am J Hematol 2004; 77(4): 391–396. Article PubMed Google Scholar Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for … WebTherapy with granulocyte-colony stimulating factor (G-CSF) and granulocyte-monocyte-colony stimulating factor (GM-CSF) caused splenomegaly and severe thrombocytopenia, which recurred upon rechallenge. We propose that myeloid growth factors may be detrimental in patients with MDS-associated hemophagocytosis.
Hemophagocytosis Exacerbated by G-CSF/GM-CSF …
WebSep 11, 2024 · Cytology of cerebrospinal fluid (CSF) was class II. Bone marrow aspiration/biopsy revealed no evidence of lymphoma or hemophagocytosis. As he had a past history of MTX-induced interstitial pneumonia, cyclophosphamide, cytosine arabinoside, dexamethasone, etoposide, and rituximab (CHASER) instead of high-dose MTX was … WebGlasser L, et al. Florid histiocytic hemophagocytosis following therapy with long acting G-CSF (pegfilgrastim). Am. J. Hematol. 82:753-757, 2007. 2. Padhi S, et al. … ipc garissa county
Hemophagocytosis Exacerbated by G-CSF/GM-CSF …
WebMay 7, 2015 · The prevalence of hemophagocytosis in the bone marrow of HLH patients ranges from 25% to 100% and reads often vary between pathologists. 24,25,51,57 Additionally, it can be commonly found in critically ill patients in the absence of HLH. 58,59 Nevertheless, the evaluation of suspected HLH should include a bone marrow biopsy. In … WebHemophagocytosis Exacerbated by G-CSF/GM-CSF Treatment in a Patient With Myelodysplasia Sa Wang,1,2 Barbara A. Degar,3 Arthur Zieske,1,2 Nelofar Q. Shafi,4 and Michal G. Rose5,6* 1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 2Department of Laboratory Medicine, Yale University School of … WebHemophagocytosis is achieved mostly by monocytes, macrophages, and nitro-blue tetrazolium reduction by monocytes from patients with HLH is approximately six times that of control monocytes . Splenic macrophages from patients with HLH exhibit an activated phenotype with increased expression of MHC class I and II molecules and increased M … opentext content transfer helper